EDAP
Price
$1.78
Change
-$0.09 (-4.81%)
Updated
Apr 3, 02:27 PM (EDT)
Capitalization
281.62M
41 days until earnings call
SRDX
Price
$30.27
Change
-$0.49 (-1.59%)
Updated
Apr 3, 03:00 PM (EDT)
Capitalization
397.04M
27 days until earnings call
Ad is loading...

EDAP vs SRDX

Header iconEDAP vs SRDX Comparison
Open Charts EDAP vs SRDXBanner chart's image
EDAP TMS SA
Price$1.78
Change-$0.09 (-4.81%)
Volume$17.28K
Capitalization281.62M
Surmodics
Price$30.27
Change-$0.49 (-1.59%)
Volume$100
Capitalization397.04M
EDAP vs SRDX Comparison Chart
Loading...
EDAP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EDAP vs. SRDX commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EDAP is a StrongBuy and SRDX is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (EDAP: $1.87 vs. SRDX: $30.76)
Brand notoriety: EDAP and SRDX are both not notable
EDAP represents the Medical Distributors, while SRDX is part of the Medical Specialties industry
Current volume relative to the 65-day Moving Average: EDAP: 239% vs. SRDX: 35%
Market capitalization -- EDAP: $281.62M vs. SRDX: $397.04M
EDAP [@Medical Distributors] is valued at $281.62M. SRDX’s [@Medical Specialties] market capitalization is $397.04M. The market cap for tickers in the [@Medical Distributors] industry ranges from $70.55B to $0. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Distributors] industry is $9.87B. The average market capitalization across the [@Medical Specialties] industry is $8.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EDAP’s FA Score shows that 0 FA rating(s) are green whileSRDX’s FA Score has 0 green FA rating(s).

  • EDAP’s FA Score: 0 green, 5 red.
  • SRDX’s FA Score: 0 green, 5 red.
According to our system of comparison, SRDX is a better buy in the long-term than EDAP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EDAP’s TA Score shows that 4 TA indicator(s) are bullish while SRDX’s TA Score has 5 bullish TA indicator(s).

  • EDAP’s TA Score: 4 bullish, 5 bearish.
  • SRDX’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, SRDX is a better buy in the short-term than EDAP.

Price Growth

EDAP (@Medical Distributors) experienced а -8.78% price change this week, while SRDX (@Medical Specialties) price change was +0.92% for the same time period.

The average weekly price growth across all stocks in the @Medical Distributors industry was -3.02%. For the same industry, the average monthly price growth was -5.38%, and the average quarterly price growth was -8.51%.

The average weekly price growth across all stocks in the @Medical Specialties industry was -3.36%. For the same industry, the average monthly price growth was +2.56%, and the average quarterly price growth was +2.31%.

Reported Earning Dates

EDAP is expected to report earnings on May 14, 2025.

SRDX is expected to report earnings on Apr 30, 2025.

Industries' Descriptions

@Medical Distributors (-3.02% weekly)

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

@Medical Specialties (-3.36% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SRDX($397M) has a higher market cap than EDAP($282M). EDAP has higher P/E ratio than SRDX: EDAP (100.00) vs SRDX (71.51). EDAP YTD gains are higher at: -15.385 vs. SRDX (-22.323). SRDX has higher annual earnings (EBITDA): 22.1M vs. EDAP (-18.39M). EDAP has more cash in the bank: 43.5M vs. SRDX (35.2M). EDAP has less debt than SRDX: EDAP (8.42M) vs SRDX (33.9M). SRDX has higher revenues than EDAP: SRDX (138M) vs EDAP (60.4M).
EDAPSRDXEDAP / SRDX
Capitalization282M397M71%
EBITDA-18.39M22.1M-83%
Gain YTD-15.385-22.32369%
P/E Ratio100.0071.51140%
Revenue60.4M138M44%
Total Cash43.5M35.2M124%
Total Debt8.42M33.9M25%
FUNDAMENTALS RATINGS
EDAP vs SRDX: Fundamental Ratings
EDAP
SRDX
OUTLOOK RATING
1..100
515
VALUATION
overvalued / fair valued / undervalued
1..100
98
Overvalued
91
Overvalued
PROFIT vs RISK RATING
1..100
10098
SMR RATING
1..100
9793
PRICE GROWTH RATING
1..100
8862
P/E GROWTH RATING
1..100
10093
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SRDX's Valuation (91) in the Medical Specialties industry is in the same range as EDAP (98) in the Biotechnology industry. This means that SRDX’s stock grew similarly to EDAP’s over the last 12 months.

SRDX's Profit vs Risk Rating (98) in the Medical Specialties industry is in the same range as EDAP (100) in the Biotechnology industry. This means that SRDX’s stock grew similarly to EDAP’s over the last 12 months.

SRDX's SMR Rating (93) in the Medical Specialties industry is in the same range as EDAP (97) in the Biotechnology industry. This means that SRDX’s stock grew similarly to EDAP’s over the last 12 months.

SRDX's Price Growth Rating (62) in the Medical Specialties industry is in the same range as EDAP (88) in the Biotechnology industry. This means that SRDX’s stock grew similarly to EDAP’s over the last 12 months.

SRDX's P/E Growth Rating (93) in the Medical Specialties industry is in the same range as EDAP (100) in the Biotechnology industry. This means that SRDX’s stock grew similarly to EDAP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
EDAPSRDX
RSI
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
74%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
70%
Bearish Trend 2 days ago
75%
Momentum
ODDS (%)
Bearish Trend 4 days ago
80%
Bullish Trend 2 days ago
65%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
62%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
69%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
69%
Advances
ODDS (%)
Bullish Trend 16 days ago
76%
Bullish Trend 7 days ago
69%
Declines
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 23 days ago
68%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
63%
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
58%
View a ticker or compare two or three
Ad is loading...
EDAP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DEYCX11.53N/A
N/A
BNY Mellon Large Cap Equity C
SCVFX28.15N/A
N/A
Allspring Small Company Value C
SRIAX12.70N/A
N/A
Gabelli SRI A
FCPGX29.74N/A
N/A
Fidelity Small Cap Growth
TEMSX8.07N/A
N/A
Nuveen Emerging Markets Eq Retiremt

EDAP and

Correlation & Price change

A.I.dvisor tells us that EDAP and AORT have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EDAP and AORT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EDAP
1D Price
Change %
EDAP100%
-4.59%
AORT - EDAP
29%
Poorly correlated
+1.54%
ENZ - EDAP
21%
Poorly correlated
-2.21%
AVNS - EDAP
21%
Poorly correlated
+1.18%
SRDX - EDAP
21%
Poorly correlated
-0.42%
UFPT - EDAP
20%
Poorly correlated
+3.36%
More

SRDX and

Correlation & Price change

A.I.dvisor tells us that SRDX and RMD have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SRDX and RMD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRDX
1D Price
Change %
SRDX100%
-0.42%
RMD - SRDX
32%
Poorly correlated
+0.31%
MBOT - SRDX
26%
Poorly correlated
+12.58%
VNRX - SRDX
26%
Poorly correlated
+4.26%
BLCO - SRDX
25%
Poorly correlated
+1.77%
UFPT - SRDX
25%
Poorly correlated
+3.36%
More